{"id":403,"date":"2025-02-10T12:00:32","date_gmt":"2025-02-10T12:00:32","guid":{"rendered":"https:\/\/burbujainfo.com\/blog\/?p=403"},"modified":"2025-02-10T12:00:32","modified_gmt":"2025-02-10T12:00:32","slug":"la-industria-farmaceutica-en-el-punto-de-mira-del-china","status":"publish","type":"post","link":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/","title":{"rendered":"La industria farmac\u00e9utica en el punto de mira del China"},"content":{"rendered":"<p>La industria farmac\u00e9utica global est\u00e1 sufriendo una transformaci\u00f3n inimaginable hace pocos a\u00f1os debido al auge de la biotecnolog\u00eda china. En 2024, <strong>aproximadamente el 30% de las licencias de medicamentos a nivel mundial se originaron en China<\/strong>, evidenciando su creciente influencia en el desarrollo farmac\u00e9utico.<\/p>\n<p>Este avance se debe en parte al retorno de cient\u00edficos formados en Estados Unidos, una fuerza laboral rentable y procesos regulatorios m\u00e1s \u00e1giles en China. Estas ventajas han permitido a las empresas chinas desarrollar medicamentos innovadores de manera m\u00e1s r\u00e1pida y econ\u00f3mica. Por ejemplo, Summit Therapeutics, respaldada por el multimillonario Bob Duggan, anunci\u00f3 que su f\u00e1rmaco, licenciado de la biotecnol\u00f3gica china Akeso, super\u00f3 al Keytruda de Merck en el tratamiento del c\u00e1ncer de pulm\u00f3n.<\/p>\n<p>Adem\u00e1s, compa\u00f1\u00edas farmac\u00e9uticas occidentales est\u00e1n colaborando cada vez m\u00e1s con biotecnol\u00f3gicas chinas para acceder a ensayos cl\u00ednicos eficientes y datos preliminares. Empresas como GSK, Merck y AstraZeneca, junto con inversores como Bain Life Sciences y General Atlantic, est\u00e1n invirtiendo significativamente en operaciones chinas para desarrollar y comercializar medicamentos \u00abbio-mejorados\u00bb para mercados globales. En 2024, el 33% de los medicamentos licenciados por grandes farmac\u00e9uticas provinieron de China, gracias a regulaciones m\u00e1s flexibles y procesos de ensayo m\u00e1s r\u00e1pidos.<\/p>\n<p>Este cambio est\u00e1 impulsando a las empresas estadounidenses a adaptarse, ya que una cartera de medicamentos innovadores desarrollados en China est\u00e1 atrayendo a negociadores farmac\u00e9uticos, ejerciendo presi\u00f3n sobre las biotecnol\u00f3gicas estadounidenses y las firmas de capital de riesgo que las respaldan.<\/p>\n<p>La innovaci\u00f3n biotecnol\u00f3gica china est\u00e1 remodelando el ecosistema de desarrollo de medicamentos en Estados Unidos, ofreciendo tratamientos m\u00e1s efectivos y asequibles, y fomentando una competencia global que beneficia a los pacientes.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La industria farmac\u00e9utica global est\u00e1 sufriendo una transformaci\u00f3n inimaginable hace pocos a\u00f1os debido al auge de la biotecnolog\u00eda china. En 2024, aproximadamente el 30% de las licencias de medicamentos a nivel mundial se originaron en China, evidenciando su creciente influencia en el desarrollo farmac\u00e9utico. Este avance se debe en parte al retorno de cient\u00edficos formados&#8230;<\/p>\n","protected":false},"author":1,"featured_media":404,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-403","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-economia"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La industria farmac\u00e9utica en el punto de mira del China - El blog de burbuja.info<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La industria farmac\u00e9utica en el punto de mira del China - El blog de burbuja.info\" \/>\n<meta property=\"og:description\" content=\"La industria farmac\u00e9utica global est\u00e1 sufriendo una transformaci\u00f3n inimaginable hace pocos a\u00f1os debido al auge de la biotecnolog\u00eda china. En 2024, aproximadamente el 30% de las licencias de medicamentos a nivel mundial se originaron en China, evidenciando su creciente influencia en el desarrollo farmac\u00e9utico. Este avance se debe en parte al retorno de cient\u00edficos formados...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/\" \/>\n<meta property=\"og:site_name\" content=\"El blog de burbuja.info\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-10T12:00:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1210\" \/>\n\t<meta property=\"og:image:height\" content=\"796\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Carlos Lopez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Carlos Lopez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/\"},\"author\":{\"name\":\"Carlos Lopez\",\"@id\":\"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/2b95a12fc8716327a484b6c59cb33fb3\"},\"headline\":\"La industria farmac\u00e9utica en el punto de mira del China\",\"datePublished\":\"2025-02-10T12:00:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/\"},\"wordCount\":306,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/2b95a12fc8716327a484b6c59cb33fb3\"},\"image\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg\",\"articleSection\":[\"economia\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/\",\"url\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/\",\"name\":\"La industria farmac\u00e9utica en el punto de mira del China - El blog de burbuja.info\",\"isPartOf\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg\",\"datePublished\":\"2025-02-10T12:00:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#primaryimage\",\"url\":\"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg\",\"contentUrl\":\"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg\",\"width\":1210,\"height\":796},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/burbujainfo.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La industria farmac\u00e9utica en el punto de mira del China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/burbujainfo.com\/blog\/#website\",\"url\":\"https:\/\/burbujainfo.com\/blog\/\",\"name\":\"El blog de burbuja.info\",\"description\":\"Noticias de econom&iacute;a, pol&iacute;tica y actualidad\",\"publisher\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/2b95a12fc8716327a484b6c59cb33fb3\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/burbujainfo.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/2b95a12fc8716327a484b6c59cb33fb3\",\"name\":\"Carlos Lopez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f23c752988949a898d8a750cf1bdef9a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f23c752988949a898d8a750cf1bdef9a?s=96&d=mm&r=g\",\"caption\":\"Carlos Lopez\"},\"logo\":{\"@id\":\"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/image\/\"},\"description\":\"Escribo en https:\/\/www.euribor.com.es y en https:\/\/burbujainfo.com\/blog\/\",\"sameAs\":[\"https:\/\/www.euribor.com.es\"],\"url\":\"https:\/\/burbujainfo.com\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La industria farmac\u00e9utica en el punto de mira del China - El blog de burbuja.info","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/","og_locale":"es_ES","og_type":"article","og_title":"La industria farmac\u00e9utica en el punto de mira del China - El blog de burbuja.info","og_description":"La industria farmac\u00e9utica global est\u00e1 sufriendo una transformaci\u00f3n inimaginable hace pocos a\u00f1os debido al auge de la biotecnolog\u00eda china. En 2024, aproximadamente el 30% de las licencias de medicamentos a nivel mundial se originaron en China, evidenciando su creciente influencia en el desarrollo farmac\u00e9utico. Este avance se debe en parte al retorno de cient\u00edficos formados...","og_url":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/","og_site_name":"El blog de burbuja.info","article_published_time":"2025-02-10T12:00:32+00:00","og_image":[{"width":1210,"height":796,"url":"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg","type":"image\/jpeg"}],"author":"Carlos Lopez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Carlos Lopez","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#article","isPartOf":{"@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/"},"author":{"name":"Carlos Lopez","@id":"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/2b95a12fc8716327a484b6c59cb33fb3"},"headline":"La industria farmac\u00e9utica en el punto de mira del China","datePublished":"2025-02-10T12:00:32+00:00","mainEntityOfPage":{"@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/"},"wordCount":306,"commentCount":0,"publisher":{"@id":"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/2b95a12fc8716327a484b6c59cb33fb3"},"image":{"@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#primaryimage"},"thumbnailUrl":"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg","articleSection":["economia"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/","url":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/","name":"La industria farmac\u00e9utica en el punto de mira del China - El blog de burbuja.info","isPartOf":{"@id":"https:\/\/burbujainfo.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#primaryimage"},"image":{"@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#primaryimage"},"thumbnailUrl":"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg","datePublished":"2025-02-10T12:00:32+00:00","breadcrumb":{"@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#primaryimage","url":"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg","contentUrl":"https:\/\/burbujainfo.com\/blog\/wp-content\/uploads\/2025\/02\/china-drugs-h.jpg","width":1210,"height":796},{"@type":"BreadcrumbList","@id":"https:\/\/burbujainfo.com\/blog\/economia\/la-industria-farmaceutica-en-el-punto-de-mira-del-china\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/burbujainfo.com\/blog\/"},{"@type":"ListItem","position":2,"name":"La industria farmac\u00e9utica en el punto de mira del China"}]},{"@type":"WebSite","@id":"https:\/\/burbujainfo.com\/blog\/#website","url":"https:\/\/burbujainfo.com\/blog\/","name":"El blog de burbuja.info","description":"Noticias de econom&iacute;a, pol&iacute;tica y actualidad","publisher":{"@id":"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/2b95a12fc8716327a484b6c59cb33fb3"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/burbujainfo.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":["Person","Organization"],"@id":"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/2b95a12fc8716327a484b6c59cb33fb3","name":"Carlos Lopez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f23c752988949a898d8a750cf1bdef9a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f23c752988949a898d8a750cf1bdef9a?s=96&d=mm&r=g","caption":"Carlos Lopez"},"logo":{"@id":"https:\/\/burbujainfo.com\/blog\/#\/schema\/person\/image\/"},"description":"Escribo en https:\/\/www.euribor.com.es y en https:\/\/burbujainfo.com\/blog\/","sameAs":["https:\/\/www.euribor.com.es"],"url":"https:\/\/burbujainfo.com\/blog\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/posts\/403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/comments?post=403"}],"version-history":[{"count":1,"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/posts\/403\/revisions"}],"predecessor-version":[{"id":405,"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/posts\/403\/revisions\/405"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/media\/404"}],"wp:attachment":[{"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/media?parent=403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/categories?post=403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/burbujainfo.com\/blog\/wp-json\/wp\/v2\/tags?post=403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}